Pancreatic cancer is one of the most aggressive cancer types. A new study from Karolinska Institutet, in collaboration with ...
For the first time, scientists have identified 27 bacteria and fungi living in our mouths that are implicated in the ...
A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer types ...
Immuneering Corporation upgraded to Strong Buy after positive phase 2a data in pancreatic cancer. Click here to find out why ...
The event, organized by the Middlesex County Office of Health Services, aims to raise awareness and funds for pancreatic ...
Truist analysts called the results "encouraging" while pointing out certain unknowns in the data. Immuneering plans to kick ...
(OS) observed at 9 months; standard of care benchmark is ~47% -- 53% progression-free survival (PFS) observed at 9 months; ...
A Cornell-led study has revealed how a deadly form of pancreatic cancer enters the bloodstream, solving a long-standing ...
New platform offers vital peer-to-peer support, shared experiences, and practical knowledge for those affected by pancreatic ...
By knocking out a protein duo’s “bodyguard” role, researchers have exposed a hidden weakness in pancreatic cancer. It’s a ...
The American Cancer Society estimates that about 67,400 Americans will be diagnosed with pancreatic cancer this year, and nearly 52,000 will die from the highly aggressive disease.
The Chosun Ilbo on MSN
Pancreatic cancer tumor disappears with combined immune cell and drug therapy
Patients with severe cancer typically seek treatment at large hospitals in Seoul. However, recent cases of successful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results